معرفی
Mario PIRISI is a Full Professor at the Department of Translational Medicine at the University of Eastern Piedmont 'Amedeo Avogadro'. His research focuses on hepatocellular carcinoma, chronic hepatitis C, and the impact of viral infections like COVID-19 and hepatitis delta virus (HDV). He leads several projects, including studies on NAFLD-associated aging and viral therapy advancements. His work bridges clinical and translational medicine, emphasizing biomarkers (e.g., extracellular vesicles) and non-invasive diagnostic tools for liver diseases. Key contributions include evaluating outcomes of immunotherapy for hepatocellular carcinoma and investigating mechanisms of viral reactivation in hospitalized patients. PIRISI collaborates internationally on hepatitis epidemiology and autoimmunity in chronic liver diseases. He has supervised multiple studies and holds grants from institutions like Gilead Sciences and the European Commission.
Research interests span liver cancer, viral hepatitis, and systemic sclerosis complications. Notable recent projects include a prospective cohort study on monolaurin’s role in reducing COVID-19 risk and a nationwide analysis of HDV burden in Italy. His clinical interests include portal hypertension prediction and management strategies for advanced liver diseases. Over 400 publications highlight his contributions to hepatology, virology, and immunology.
